|
ZDHHC21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06430420032666E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4359002875608E-10 |
| Normal-vs-Stage2 |
1.23910000005001E-06 |
| Normal-vs-Stage3 |
5.54049994772043E-09 |
| Normal-vs-Stage4 |
2.4087000000006E-05 |
| Stage1-vs-Stage2 |
9.814000E-01 |
| Stage1-vs-Stage3 |
4.825400E-01 |
| Stage1-vs-Stage4 |
4.682000E-01 |
| Stage2-vs-Stage3 |
5.798200E-01 |
| Stage2-vs-Stage4 |
4.285000E-01 |
| Stage3-vs-Stage4 |
6.343600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.88618043195765E-12 |
| Normal-vs-AfricanAmerican |
1.07670000004667E-06 |
| Normal-vs-Asian |
3.629200E-04 |
| Caucasian-vs-AfricanAmerican |
1.536620E-01 |
| Caucasian-vs-Asian |
6.010200E-01 |
| AfricanAmerican-vs-Asian |
3.442600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74105174721717E-12 |
| Normal-vs-Female |
1.72877999999876E-05 |
| Male-vs-Female |
2.617000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.5099399999996E-05 |
| Normal-vs-Extreme_Weight |
7.00950408827339E-11 |
| Normal-vs-Obese |
5.31789945412697E-10 |
| Normal-vs-Extreme_Obese |
3.978000E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.135760E-01 |
| Normal_Weight-vs-Obese |
6.889000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.725800E-01 |
| Extreme_Weight-vs-Obese |
1.200990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.366800E-01 |
| Obese-vs-Extreme_Obese |
9.117000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.81810000282812E-08 |
| Normal-vs-Age(41-60Yrs) |
2.0053000371334E-09 |
| Normal-vs-Age(61-80Yrs) |
3.16390025290048E-10 |
| Normal-vs-Age(81-100Yrs) |
8.31200000050991E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.740630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.080200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.267400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.071590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.409420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.152200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
4.57080000515475E-08 |
| Normal-VS-KIRP CIMP |
1.591670E-04 |
| Normal-VS-Unclassified PRCC |
2.98310000035329E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.658400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.686800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.537050E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.057000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.165800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.180600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46579970383698E-10 |
| Normal-vs-N1 |
3.30299998463346E-09 |
| Normal-vs-N2 |
7.977000E-04 |
| N0-vs-N1 |
6.448200E-01 |
| N0-vs-N2 |
3.441000E-01 |
| N1-vs-N2 |
2.635400E-01 |
|
|
